Stay updated on AL101 in ACC with Notch Mutations Clinical Trial
Sign up to get notified when there's something new on the AL101 in ACC with Notch Mutations Clinical Trial page.

Latest updates to the AL101 in ACC with Notch Mutations Clinical Trial page
- CheckyesterdayNo Change Detected
- Check8 days agoChange DetectedThe clinical trial record for the completed AL101 study in patients with adenoid cystic carcinoma and activating Notch mutations is displayed, including study details, eligibility, locations, outcomes, and supporting documents.SummaryDifference49%

- Check15 days agoChange DetectedThe page remains a 403 Forbidden error page, while the footer revision identifier changes from v3.7.2 to v3.8.0.SummaryDifference0.2%

- Check22 days agoChange DetectedA site-wide NIH notice announces that agencies are transitioning from the term “Artificial Intelligence” to “Super Intelligence.” The clinical trial record itself remains unavailable.SummaryDifference1%

- Check29 days agoChange DetectedThe footer now displays site revision v3.7.2 instead of v3.7.1.SummaryDifference0.2%

- Check36 days agoChange DetectedThe site footer revision changed from v3.7.0 to v3.7.1 while the page continued to display a 403 Forbidden error.SummaryDifference0.2%

- Check57 days agoChange DetectedThe page now displays a 403 Forbidden error, replacing the study record content with an access-denied message; the prior study details have been removed from view.SummaryDifference17%

Stay in the know with updates to AL101 in ACC with Notch Mutations Clinical Trial
Enter your email address, and we'll notify you when there's something new on the AL101 in ACC with Notch Mutations Clinical Trial page.